Opinion

Video

The Current Treatment Landscape for R/R CLL

Author(s):

Nitin Jain, MD,Joanna M. Rhodes, MD, MSCE

Panelists discuss the current standard of care and treatment landscape for patients with chronic lymphocytic leukemia.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Video content above is prompted by the following:

    • Please discuss the current treatment landscape for relapse/refractory chronic lymphocytic leukemia.
    Related Videos
    2 experts in this video
    Key Updates in the Treatment of ES-SCLC
    2 experts in this video
    Expert Insights on Recent Advancements in LS-SCLC
    2 expert is featured in this series.
    Logistical Considerations for Delivering TCR Therapy to Patients
    2 expert is featured in this series.
    Comparing Postinfusion Challenges in TCR Therapy and Standard-of-Care Regimens
    SABCS 2024: Promising Studies in HR+ and HER2– mBC and Early-Stage TNBC
    SABCS 2024: Promising Studies in HR+ and HER2– mBC and Early-Stage TNBC
    2 experts are featured in this series.
    Key Takeaways and Future Perspectives for In-House Biomarker Testing
    Sequencing Sections for Patients With Both BRCA Mutations and Early-Stage TNBC
    Sequencing Sections for Patients With Both BRCA Mutations and Early-Stage TNBC
    2 expert is featured in this series.
    Potential Impact of Afami-Cel Therapy on the Standard of Care for R/R Cases
    2 expert is featured in this series.
    Approaches to First-Line Treatment for Synovial Sarcoma
    2 experts are featured in this series.
    Mitigating Socioeconomic Disparities Through Decentralized Testing: Overcoming Barriers to Access and Equity
    Related Content